Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-09-24
DOI
10.1038/s41598-022-20164-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
- (2022) Kjetil Bjornevik et al. SCIENCE
- Protective effects of melatonin on changes occurring in the experimental autoimmune encephalomyelitis model of multiple sclerosis
- (2022) Begoña María Escribano et al. Multiple Sclerosis and Related Disorders
- Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO
- (2021) Minah Kim et al. Frontiers in Immunology
- Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease
- (2021) Li-Ming Chen et al. Journal of Neuroinflammation
- The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?
- (2021) Niklas Joisten et al. TRENDS IN MOLECULAR MEDICINE
- A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity
- (2021) Eleanor L. Hopkins et al. Frontiers in Molecular Biosciences
- Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression
- (2020) Gayathri Sundaram et al. Journal of Neuroinflammation
- Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
- (2020) Tamás Biernacki et al. Cells
- Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome
- (2020) Xin Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Mitchell T Wallin et al. LANCET NEUROLOGY
- Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis
- (2019) Majid Ghareghani et al. Frontiers in Pharmacology
- Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care
- (2019) Anna Tarocco et al. Cell Death & Disease
- Dysregulation of BDNF in Prefrontal Cortex in Alzheimer’s Disease
- (2019) Toby Aarons et al. JOURNAL OF ALZHEIMERS DISEASE
- Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis
- (2019) Vanessa X. Tan et al. Frontiers in Neuroscience
- Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology
- (2019) Jana K. Sonner et al. Nature Communications
- Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma
- (2019) Soudabeh Rad Pour et al. Scientific Reports
- Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
- (2019) Amit Bar-Or et al. TRENDS IN MOLECULAR MEDICINE
- Estudio comparativo de melatonina contra los tratamientos inmunomoduladores (interferón beta y acetato de glatirámero) en un modelo murino de esclerosis múltiple
- (2018) E.J. Ramos González et al. NEUROLOGIA
- Melatonin as an endogenous regulator of diseases: The role of autophagy
- (2018) Ali Roohbakhsh et al. PHARMACOLOGICAL RESEARCH
- The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors
- (2018) Ana C. R. Moreno et al. Frontiers in Immunology
- Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation
- (2018) Paras S. Minhas et al. NATURE IMMUNOLOGY
- Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway
- (2018) Majid Ghareghani et al. Frontiers in Immunology
- TCDD, FICZ, and Other High Affinity AhR Ligands Dose-Dependently Determine the Fate of CD4+ T Cell Differentiation
- (2017) Allison K Ehrlich et al. TOXICOLOGICAL SCIENCES
- Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis
- (2017) Tobias V. Lanz et al. Scientific Reports
- Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
- (2017) Chai K. Lim et al. Scientific Reports
- Anti-inflammatory effects of melatonin in multiple sclerosis
- (2016) Mauricio F. Farez et al. BIOESSAYS
- Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
- (2016) Michael D. Lovelace et al. Frontiers in Immunology
- Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance
- (2015) Nuria Álvarez-Sánchez et al. BRAIN BEHAVIOR AND IMMUNITY
- Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses
- (2015) Mauricio F. Farez et al. CELL
- Prenatal maternal immune activation increases anxiety- and depressive-like behaviors in offspring with experimental autoimmune encephalomyelitis
- (2015) J. Majidi-Zolbanin et al. NEUROSCIENCE
- Neurostereology protocol for unbiased quantification of neuronal injury and neurodegeneration
- (2015) Victoria M. Golub et al. Frontiers in Aging Neuroscience
- Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis
- (2013) Nady Braidy et al. BRAIN RESEARCH
- Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets
- (2013) Rafael Lugo-Huitrón et al. Oxidative Medicine and Cellular Longevity
- Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain
- (2013) Wei Wu et al. PLoS One
- Quinolinic acid: neurotoxicity
- (2012) Gilles J. Guillemin FEBS Journal
- Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration
- (2012) Emanuela Colombo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NAD+metabolism and oxidative stress: the golden nucleotide on a crown of thorns
- (2012) Hassina Massudi et al. REDOX REPORT
- On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
- (2011) R. Lugo-Huitrón et al. NEUROTOXICOLOGY AND TERATOLOGY
- Melatonin Promotes Myelination by Decreasing White Matter Inflammation After Neonatal Stroke
- (2010) Sonia Villapol et al. PEDIATRIC RESEARCH
- N-acetylserotonin activates TrkB receptor in a circadian rhythm
- (2010) Sung-Wuk Jang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase
- (2009) Silvia K. Schmidt et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The aryl hydrocarbon receptor: a regulator of Th17 and Treg cell development in disease
- (2008) Peggy P Ho et al. CELL RESEARCH
- The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
- (2008) Marc Veldhoen et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started